BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33118056)

  • 1. Experimental and clinical studies on radiation and curcumin in human glioma.
    Sminia P; van den Berg J; van Kootwijk A; Hageman E; Slotman BJ; Verbakel WFAR
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):403-409. PubMed ID: 33118056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Enhancing Effects of Curcumin on Radiotherapy with F98/
    Wang WH; Shen CY; Chien YC; Chang WS; Tsai CW; Lin YH; Hwang JJ
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential radiosensitizing potential of temozolomide in MGMT promoter methylated glioblastoma multiforme cell lines.
    van Nifterik KA; van den Berg J; Stalpers LJ; Lafleur MV; Leenstra S; Slotman BJ; Hulsebos TJ; Sminia P
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1246-53. PubMed ID: 17967314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective of curcumin, a pleiotropic signalling molecule from Curcuma longa in the treatment of Glioblastoma.
    Luthra PM; Lal N
    Eur J Med Chem; 2016 Feb; 109():23-35. PubMed ID: 26748069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DTCM-glutarimide Delays Growth and Radiosensitizes Glioblastoma.
    Roberto GM; Paiva HH; Botelho de Souza LE; Pezuk JA; Vieira GM; de Oliveira HF; Umezawa K; Tone LG; Brassesco MS
    Anticancer Agents Med Chem; 2018; 18(9):1323-1329. PubMed ID: 29683097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Potential of Curcumin in the Treatment of Glioblastoma Multiforme.
    Shahcheraghi SH; Zangui M; Lotfi M; Ghayour-Mobarhan M; Ghorbani A; Jaliani HZ; Sadeghnia HR; Sahebkar A
    Curr Pharm Des; 2019; 25(3):333-342. PubMed ID: 30864499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma differentiation-associated 7 (interleukin 24) inhibits growth and enhances radiosensitivity of glioma cells in vitro and in vivo.
    Yacoub A; Mitchell C; Lister A; Lebedeva IV; Sarkar D; Su ZZ; Sigmon C; McKinstry R; Ramakrishnan V; Qiao L; Broaddus WC; Gopalkrishnan RV; Grant S; Fisher PB; Dent P
    Clin Cancer Res; 2003 Aug; 9(9):3272-81. PubMed ID: 12960112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mangiferin induces radiosensitization in glioblastoma cells by inhibiting nonhomologous end joining.
    Mu F; Liu T; Zheng H; Xie X; Lei T; He X; Du S; Tong R; Wang Y
    Oncol Rep; 2018 Dec; 40(6):3663-3673. PubMed ID: 30272350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant administration of radiation with eribulin improves the survival of mice harboring intracerebral glioblastoma.
    Miki S; Imamichi S; Fujimori H; Tomiyama A; Fujimoto K; Satomi K; Matsushita Y; Matsuzaki S; Takahashi M; Ishikawa E; Yamamoto T; Matsumura A; Mukasa A; Nishikawa R; Masutomi K; Narita Y; Masutani M; Ichimura K
    Cancer Sci; 2018 Jul; 109(7):2275-2285. PubMed ID: 29758120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines.
    Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q
    Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy.
    Kundu P; Mohanty C; Sahoo SK
    Acta Biomater; 2012 Jul; 8(7):2670-87. PubMed ID: 22484149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of trans sodium crocetinate for sensitizing glioblastoma multiforme to radiation: laboratory investigation.
    Sheehan J; Ionescu A; Pouratian N; Hamilton DK; Schlesinger D; Oskouian RJ; Sansur C
    J Neurosurg; 2008 May; 108(5):972-8. PubMed ID: 18447715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GBM radiosensitizers: dead in the water…or just the beginning?
    Bindra RS; Chalmers AJ; Evans S; Dewhirst M
    J Neurooncol; 2017 Sep; 134(3):513-521. PubMed ID: 28762004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
    Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Combined Approach Employing Chlorotoxin-Nanovectors and Low Dose Radiation To Reach Infiltrating Tumor Niches in Glioblastoma.
    Tamborini M; Locatelli E; Rasile M; Monaco I; Rodighiero S; Corradini I; Franchini MC; Passoni L; Matteoli M
    ACS Nano; 2016 Feb; 10(2):2509-20. PubMed ID: 26745323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin increases efficiency of γ-irradiation in gliomas by inhibiting Hedgehog signaling pathway.
    Meng X; Cai J; Liu J; Han B; Gao F; Gao W; Zhang Y; Zhang J; Zhao Z; Jiang C
    Cell Cycle; 2017 Jun; 16(12):1181-1192. PubMed ID: 28463091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas.
    Minea RO; Duc TC; Swenson SD; Cho HY; Huang M; Hartman H; Hofman FM; Schönthal AH; Chen TC
    PLoS One; 2020; 15(9):e0238238. PubMed ID: 32881880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma.
    Narayan RS; Gasol A; Slangen PLG; Cornelissen FMG; Lagerweij T; Veldman HYYE; Dik R; van den Berg J; Slotman BJ; Würdinger T; Haas-Kogan DA; Stalpers LJA; Baumert BG; Westerman BA; Theys J; Sminia P
    Mol Cancer Ther; 2018 Feb; 17(2):347-354. PubMed ID: 28958992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.